Taser Heart Risk Highlighted By New Study
Although the manufacturer of the Taser stun gun has maintained that the device delivers a non-life threatening electrical charge, new research suggests that a Taser shot to the chest may…
Tag Archives:
-
-
Despite Bleed Problems, Pradaxa Sales Soar
Boehringer Ingleheim’s relatively new anticoagulant Pradaxa has hit blockbuster status, even amid hundreds of deaths and other serious injuries caused by bleeding problems experienced by users of the medication.
-
SSRI Antidepressants Do More Harm Than Good: Study
A new study raises serious questions about the wide-spread use of SSRI antidepressants, which include popular medications like Paxil, Zoloft and Prozac. Researchers indicate that the side effects associated with…
-
Bladder Cancer Risk Leads to Actos Limitations in Ontario
The Canadian province of Ontario is limiting patient access to Actos, due to the risk of bladder cancer associated with long-term use of the diabetes drug.
-
Medtronic Pain Pump Lawsuit Brought By Paralyzed Man Dismissed
A federal court has upheld the dismissal of a product liability lawsuit brought by an Arizona man who was allegedly paralyzed due to problems with a Medtronic pain pump.
-
IVF Fertility Treatment Linked to Higher Risk of Birth Defects: Study
Children conceived using in vitro fertilization (IVF) or other fertility treatment may face an increased risk of being born with birth defects, according to new research.
-
Yaz, Yasmin Settlement Negotiations Continue, as Stay Extended Again
The federal judge presiding over the Yaz and Yasmin MDL has pushed back all deadlines another 90 days, allowing settlement negotiations to continue between Bayer and plaintiffs’ lawyers throughout the…
-
Lawsuits Over DePuy Pinnacle Hip Replacements Moving Forward in MDL
Lawyers involved in the federal litigation over problems with DePuy Pinnacle hip replacements are scheduled to meet with the MDL Court this week, where they are expected to discuss a…
-
Victoza Recall Request Dismissed by Drug Maker
A recent petition filed to remove Victoza from the market is groundless, according to Novo Nordisk, and the manufacturer of the diabetes drug indicates that it does not expect that…
